Tigecycline
- Product NDC
- 70594-035
- 11-digit product format
- 705940035
- Labeler code
- 70594
- Product ID
- 70594-035_9ba6400d-4bf6-44e1-9dc7-91302381cb90
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tigecycline
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Xellia Pharmaceuticals USA LLC
- Application
- ANDA205722
- Marketing category
- ANDA
- Marketing start
- 2020-02-01
- Marketing end
- 0000-00-00
- Substance
- TIGECYCLINE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Tetracycline-class Antibacterial [EPC],Tetracyclines [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70594-035-02 | 70594003502 | 10 VIAL, GLASS in 1 CARTON (70594-035-02) > 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (70594-035-01) | 2020-02-01 | 0000-00-00 | No | No | Current |